A relationship between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare immune system cancer, has been found by the US Food and Drug Administration (FDA). This condition has been termed breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The FDA thinks that women with breast implants with textured surfaces are very low in BIA-ALCL but BIA-ALCL risk is increased. However, this does not indicate that these implants cause BIA-ALCL. More research is needed to understand the relationship between the condition and breast implants.